Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Return on Capital Employed (2018 - 2020)

enVVeno Medical has reported Return on Capital Employed over the past 3 years, most recently at 163.01% for Q4 2020.

  • For Q4 2020, Return on Capital Employed rose 11953.0% year-over-year to 163.01%; the TTM value through Dec 2020 reached 163.01%, up 11953.0%, while the annual FY2020 figure was 240.41%, 23323.0% up from the prior year.
  • Return on Capital Employed for Q4 2020 was 163.01% at enVVeno Medical, up from 209.52% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 152.17% in Q2 2019 and troughed at 2408.18% in Q2 2020.
  • A 3-year average of 536.87% and a median of 264.06% in 2018 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 11953bps in 2020 and fell as far as -225601bps in 2020.
  • Year by year, Return on Capital Employed stood at 264.06% in 2018, then fell by -7bps to 282.54% in 2019, then surged by 42bps to 163.01% in 2020.
  • Business Quant data shows Return on Capital Employed for NVNO at 163.01% in Q4 2020, 209.52% in Q3 2020, and 2408.18% in Q2 2020.